YJ9069
YJ9069 is a selective CDK12/CDK13 PROTAC degrader with an IC50 of 22.22 nM for in VCaP cells. CDK12/13 degradation rapidly triggers gene-length-dependent transcriptional elongation defects, leading to DNA damage and cell-cycle arrest. YJ9069 effectively inhibits proliferation in subsets of prostate cancer cells and significantly suppresses prostate tumor growth. (Pink: CDK12/CDK13 degradation agent ; Black: Linker (HY-W015967) ; Blue: ligand for E3 ligase (HY-103596) ).
Product Specifications
UNSPSC
12352005
Target
CDK; DNA/RNA Synthesis; PROTACs
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/yj9069.html
Purity
97.63
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(NCC1=CC=CC=C1)N(C2=CN=C(N3CCN(C(COC4=C5C(C(N(C6CCC(NC6=O)=O)C5=O)=O)=CC=C4)=O)CC3)C=C2)[C@H](CC7)CC[C@@H]7NC8=NC=C9C(C=CC=C9)=N8
Molecular Formula
C46H46N10O7
Molecular Weight
850.92
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK12; CDK13
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Progesterone (6-5E-3F), CF594 conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF647 conjugate, 0.1mg/mL
